Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: Analysis of overall and septic complications in 68 cases using a single type of device

Bone Marrow Transplantation

Volumn 24, Issue 1, 1999, Pages 89-93

  Biffi, R ^a   Martinelli, G ^a   Pozzi, S ^a   Cinieri, S ^a   Cocorocchio, E ^a   Peccatori, F ^a   Ferrucci, Pf ^a   Pistorio, R ^a   Andreoni, B ^a  

^a EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Autologous stem cell transplantation; Central venous catheters; High dose chemotherapy; Ports

Indexed keywords

ANTIBIOTIC AGENT; ANTIEMETIC AGENT; CARBOPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; IFOSFAMIDE; MELPHALAN;

ADULT; ARTICLE; AUTOTRANSPLANTATION; BLOOD SAMPLING; BREAST CANCER; CANCER CHEMOTHERAPY; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CLINICAL TRIAL; FEMALE; FLUID THERAPY; HUMAN; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NEUTROPENIA; OVARY CANCER; PNEUMOTHORAX; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEPSIS; STEM CELL TRANSPLANTATION; STREPTOCOCCUS MITIS; SUBCLAVIAN VEIN;

EID: 0032767881     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701822     Document Type: Article

References (34)

1. Broviac JW, Cole JJ, Scribner BH. A silicone rubber atrial catheter for prolonged parenteral alimentation. Surg Gynecol Obstet 1973; 136: 602-606.
2. Hickman RO, Buckner CD, Clift RA et al. A modified right atrial catheter for access to the venous system in marrow transplant recipients. Surg Gynecol Obstet 1979; 148: 871-875.
3. Moosa HH, Julian TB, Rosenfeld CS, Shadduck RK. Complications of indwelling central venous catheters in bone marrow transplant recipients. Surg Gynecol Obstet 1991; 172: 275-279.
4. Raad I, Davis S, Becker M et al. Low infection rate and long durability of nontunneled silastic catheters. A safe and cost-effective alternative for long-term vascular access. Arch Intern Med 1993; 153: 1791-1796.
5. Simon C, Suttorp M. Results of antibiotic treatment of Hickman-catheter-related infections in oncological patients. Support Care Cancer 1994; 2: 66-70.
6. Biffi R, Corrado F, De Braud F et al. Long-term totally implantable central venous access ports connected to a Groshong catheter for chemotherapy of solid tumours: experience from 178 cases using a single type of device. Eur J Cancer 1997; 33: 1190-1194.
7. Mathur MN, Storey DW, White GH et al. Percutaneous insertion of long-term venous access catheters via the external iliac vein. Aust NZ J Surg 1993; 63: 858-863.
8. Keung YK, Watkins K, Chen SC et al. Increased incidence of central venous catheter-related infections in bone marrow transplant patients. Am J Clin Oncol 1995; 18: 469-474.
9. McCready D, Broadwater R, Ross M et al. A case-control comparison of durability and cost between implanted reservoir and percutaneous catheters in cancer patients. J Surg Res 1991; 51: 377-381.
10. Biffi R, De Braud F, Orsi F et al. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs in 333 devices with a minimum 180 days of follow-up. Ann Oncol 1998; 9: 767-773.
11. Hayward SR, Ledgerwood AM, Lucas CT. The fate of 100 prolonged venous access devices. Am Surg 1990; 56: 515-519.
12. Brothers TE, Von Moll LK, Niederhuber JE et al. Experience with subcutaneous infusion ports in the three hundred patients. Surg Gynecol Obstet 1988; 166: 295-301.
13. Morrison VA, Peterson BA, Bloomfield CD. Nosocomial septicemia in the cancer patient: the influence of central venous access devices, neutropenia and type of malignancy. Med Pediatr Oncol 1990; 18: 209-216.
14. Greene FL, Moore W, Strickland G, McFarland J. Comparison of a totally implantable access device for chemotherapy (Port-A-Cath) and long-term percutaneous catheterization (Broviac). South Med J 1988; 81: 580-583.
15. Mueller BU, Skelton J, Callender DPE et al. A prospective randomized trial comparing the infectious and noninfectious complications of an externalized catheter versus a subcutaneously implanted device in cancer patients. J Clin Oncol 1992; 10: 1943-1948.
16. Groeger JS, Lucas AB, Thaler HT et al. Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 1993; 119: 1168-1174.
17. Reed WP, Newman KA, De Jongh C et al. Prolonged venous access for chemotherapy by means of the Hickman catheter. Cancer 1983; 52: 185-192.
18. Howell PB, Walters PE, Donowitz GR, Fair BM. Risk factors for infection of adult patients with cancer who have tunnelled central venous catheters. Cancer 1995; 75: 1367-1375.
19. Pasquale MD, Campbell JM, Magnant CM. Groshong versus Hickman catheters. Surg Gynecol Obstet 1992; 174: 408-410.
20. Stanislav GV, Fitzgibbons RJ, Bailey RT et al. Reliability of implantable central venous access devices in patients with cancer. Arch Surg 1987; 122: 1280-1283.
21. Gleeson NC, Fiorica JV, Mark JE et al. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients. Gynecol Oncol 1993; 51: 372-376.
22. Koonings PP, Given FT. Long term experience with a totally implanted catheter system in gynecologic oncologic patients. J Am Coll Surg 1994; 178: 164-166.
23. Malviya VK, Gunter D, Gove N, Malone JM Jr. Vascular access in gynecologic cancer using the Groshong right atrial catheter. Gynecol Oncol 1989; 33: 313-316.
24. Delmore JE, Horbelt DV, Jack BL, Roberts RK. Experience with the Groshong long-term central venous catheter. Gynecol Oncol 1989; 34: 216-218.
25. Hull JE, Hunter CS, Luiken GA. The Groshong catheter: initial experience and early results of imaging-guided placement. Radiology 1992; 185: 803-807.
26. Uderzo G, D'Angelo P, Rizzari C et al. Central venous catheter-related complications after bone marrow transplantation in children with hematological malignancies. Bone Marrow Transplant 1992; 9: 113-117.
27. Madero L, Ruano D, Villa M et al. Non-tunneled catheters in children undergoing bone marrow transplantation. Bone Marrow Transplant 1996; 17: 87-89.
28. Aubaniac R. L'injection intraveineuse sous-claviculaire; avantages et technique Presse Med 1952; 60: 1456-1458.
29. Home III MK, May DJ, Alexander HR et al. Venographic surveillance of tunneled venous access devices in adult oncology patients. Ann Surg Oncol 1995; 2: 174-178.
30. Haire WD, Lieberman RP, Edney J et al. Hickman catheter-induced thoracic vein thrombosis: frequency and long-term sequelae in patients receiving high-dose chemotherapy and marrow transplantation. Cancer 1990; 66: 900-908.
31. Bern MM, Lokich JJ, Wallach SR et al. Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 1990; 112: 423-428.
32. Monreal M, Alastrue A, Rull M et al. Upper extremity deep vein thrombosis in cancer patients with venous access devices - prophylaxis with a low molecular weight heparin (Fragmin). Thromb Haemost 1996; 75: 251-253.
33. Gianni AM, Bregni M, Siena S et al. High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphomas. New Engl J Med 1997; 336: 1290-1297.
34. Barlogie B, Jagannath S, Naucke S et al. Long-term follow-up after high-dose therapy for high-risk multiple myeloma. Bone Marrow Transplant 1998; 21: 1101-1107.